Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19704057

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Oct 1
First author
Rinke A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Oct 1;27(28):4635-6. doi: 10.1200/JCO.2009.23.6711.
    note
    Source null
    related pmid
    19704053
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Jan 20;28(3):e41-2; author reply e43-4. doi: 10.1200/JCO.2009.26.0612.
    note
    Source null
    related pmid
    20008618
    relationship
    Comment in
  3. citation
    Nat Rev Endocrinol. 2010 Apr;6(4):188-9. doi: 10.1038/nrendo.2010.3.
    note
    Source null
    related pmid
    20336162
    relationship
    Comment in
  4. citation
    Acta Oncol. 2014 Oct;53(10):1283. doi: 10.3109/0284186X.2014.966921.
    note
    Source null
    related pmid
    25327263
    relationship
    Comment in

Authors and identifiers

  1. name
    Rinke A
    type
    Author
  2. name
    Müller HH
    type
    Author
  3. name
    Schade-Brittinger C
    type
    Author
  4. name
    Klose KJ
    type
    Author
  5. name
    Barth P
    type
    Author
  6. name
    Wied M
    type
    Author
  7. name
    Mayer C
    type
    Author
  8. name
    Aminossadati B
    type
    Author
  9. name
    Pape UF
    type
    Author
  10. name
    Bläker M
    type
    Author
  11. name
    Harder J
    type
    Author
  12. name
    Arnold C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rinke A
    type
    Author
  2. name
    Müller HH
    type
    Author
  3. name
    Schade-Brittinger C
    type
    Author
  4. name
    Klose KJ
    type
    Author
  5. name
    Barth P
    type
    Author
  6. name
    Wied M
    type
    Author
  7. name
    Mayer C
    type
    Author
  8. name
    Aminossadati B
    type
    Author
  9. name
    Pape UF
    type
    Author
  10. name
    Bläker M
    type
    Author
  11. name
    Harder J
    type
    Author
  12. name
    Arnold C
    type
    Author
bibliography ids
  1. nci-bib-d08879226b511e4d94751177
book metadata
content sha256
0e5013562c426c544f718fcae2caf53c34343be309d167b72254f2f96a4961dc
document type
citation
dois
  1. 10.1200/JCO.2009.22.8510
electronic publication date
display
2009 Aug 24
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19704057
immutable id
pubmed:19704057@0e5013562c426c544f718fcae2caf53c34343be309d167b72254f2f96a4961dc
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
28
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4656-63
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Oct 1;27(28):4635-6. doi: 10.1200/JCO.2009.23.6711.
    note
    Source null
    related pmid
    19704053
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Jan 20;28(3):e41-2; author reply e43-4. doi: 10.1200/JCO.2009.26.0612.
    note
    Source null
    related pmid
    20008618
    relationship
    Comment in
  3. citation
    Nat Rev Endocrinol. 2010 Apr;6(4):188-9. doi: 10.1038/nrendo.2010.3.
    note
    Source null
    related pmid
    20336162
    relationship
    Comment in
  4. citation
    Acta Oncol. 2014 Oct;53(10):1283. doi: 10.3109/0284186X.2014.966921.
    note
    Source null
    related pmid
    25327263
    relationship
    Comment in
outcomes validated
false
pmid
19704057
provenance
batch id
0706b5111d1451f52f74
provider
NCBI PubMed ESummary
record sha256
5b915963172cff5fc7823e03a2e783540b513348abe8d9e99366ee6210b05b86
response sha256
98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
retrieved at
2026-09-09T23:46:29.215195+00:00
publication date
display
2009 Oct 1
precision
day
year
2009
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19704057/
title
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Preserved source evidence · Not medical advice